Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling

Bioconjugate Chemistry

Volumn 19, Issue 7, 2008, Pages 1476-1484

  Boswell, C Andrew ^a,c   Regino, Celeste A S ^a   Baidoo, Kwamena E ^a   Wong, Karen J ^a   Bumb, Ambika ^a   Xu, Heng ^a   Milenic, Diane E ^a   Kelley, James A ^b   Lai, Christopher C ^b   Brechbiel, Martin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER COMPOUNDS; ETHYLENE; PEPTIDES; POSITRON EMISSION TOMOGRAPHY;

BI-FUNCTIONAL; BIOLOGICAL MOLECULE; COVALENT ATTACHMENT; CROSS-BRIDGED CYCLAM; CYCLAM DERIVATIVES; HEXADECANE; IN-VIVO; RADIOLABELLING; STABLE COMPLEXES; TETRAAZA MACROCYCLE;

CHELATION;

1,4,8,11 TETRAAZACYCLOTETRADECANE 1,4,8,11 TETRAACETIC ACID; 4,11 BIS(CARBO TERT BUTOXYMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE; ACETIC ACID; COPPER 64; CYCLAM DERIVATIVE; MACROCYCLIC COMPOUND; PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPLEX FORMATION; DRUG CONJUGATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY;

EID: 47749112426     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800039e     Document Type: Article

References (39)

1. + complexation in a diamond-lattice cleft. J. Am. Chem. Soc. 112, 8604-8605.
2. Weisman, G. R., Wong, E. H., Hill, D. C., Rogers, M. E., Reed, D. P., and Calabrese, J. C. (1996) Synthesis and transition-metal complexes of new cross-bridged tetraamine ligands. J. Chem. Soc. Chem. Commun. 947-948.
3. Wong, E. H., Weisman, G. R., Hill, D. C., Reed, D. P., Rogers, M. E., Condon, J. P., Fagan, M. A., Calabrese, J. C., Lam, K.-C., Guzei, I. A., and Rheingold, A. L. (2000) Synthesis and characterization of cross-bridged cyclams and pendant-armed derivatives and structural studies of their copper(II) complexes. J. Am. Chem. Soc. 122, 10561-10572.
4. Hubin, T. J., Alcock, N. W., and Busch, D. H. (2000) Copper(I) and copper(II) complexes of an ethylene cross-bridged cyclam. Acta Crystallogr., Sect. C 56, 37-39.
5. Hubin, T. J., Alcock, N. W., Morton, M. D., and Busch, D. H. (2003) Synthesis, structure, and stability in acid of copper(II) and zinc(II) complexes of cross-bridged tetraazamacrocycles. Inorg. Chim. Acta 348, 33-40.
6. Hubin, T. J., McCormick, J. M., Alcock, N. W., Clase, H. J., and Busch, D. H. (1999) Crystallographic characterization of stepwise changes in ligand conformation as their internal topology changes and two novel cross-bridged tetraazamacrocyclic copper(II) complexes. Inorg. Chem. 38, 4435-4446.
7. Hubin, T. J., McCormick, J. M., Collinson, S. R., Alcock, N. W., and Busch, D. H. (1998) Ultra rigid cross-bridged tetraazamacrocycles as ligands - the challenge and the solution. J. Chem. Soc., Chem. Commun. 1675-1676.
8. Springborg, J., Glerup, J., and Sotofte, I. (1997) Synthesis and crystal structure of a compound with three [24.31]adamanzanecopper(II) species coordinated to one carbonate ion, m3-carbonatotris-{1,4,7,10-tetraazabicyclo[5. 5.3]pentadecanecopper(U)} perchlorate dihydrate. Acta Chem. Scand. 51, 832-838.
9. Springborg, J., Kofod, P., Olsen, C. E., and Sotofte, I. (1995) Synthesis and crystal structure of a small bicyclic tetraaza proton sponge, 1,4,7,10-tetraazabicyclo[5.5.3]pentadecane dibromide Perchlorate. Acta Chem. Scand. 49, 547-554.
10. Springborg, J., Pretzmann, U., Nielsen, B., Olsen, C. E., and Sotofte, I. (1998) Synthesis of [35]adamanzane, 1,5,9,13-tetraazatricyclo[7.7.3]nonadecane, by oxidative C-N cleavage of [36]adamanzane, 1,5,9,13-tetraazatricyclo[7.7.3. 35,13]docosane, and crystal structure of the tetraprotonated bromide salt of [35]adamanzane. Acta Chem. Scand. 52, 212.
11. Springborg, J., and Sotofte, I. (1997) Synthetic, thermodynamic and crystallographic studies of pentacoordinated copper(II) complexes with [24.31]adamanzane, 1,4,7,10-tetrazabicyclo-[5.5.3]pentadecane, and bromide, iodide, hydroxide, water, or ammonia. Acta Chem. Scand. 51, 357-366.
12. Bencini, A., Bianchi, A., Bazzicalupi, C., Ciampolini, M., Dapporto, P., Fusi, V., Micheloni, M., Nardi, N., Paoli, P., and Valtancoli, B. (1993) Synthesis and characterization of and aza-cage behaving as a 'proton sponge'. Crystal structures of its mono- and tri-protonated species. J. Chem. Soc., Perkin Trans. 2, 115-120.
13. Bencini, A., Bianchi, A., Bazzicalupi, C., Ciampolini, M., Dapporto, P., Fusi, V., Micheloni, M., Nardi, N., Paoli, P., and Valtancoli, B. (1993) Synthesis and characterization of an azacage, basicity behaviour and crystal structure of its diprotonated species. J. Chem. Soc., Perkin Trans. 2, 715-720.
14. 4] salts. J. Chem. Soc., Perkin Trans. 2, 209-214.
15. Bencini, A., Fusi, V., Giorgi, C., Micheloni, M., Nardi, N., and Valtancoli, B. (1996) Aza-macrocycles bearing lipophilic functions. Their synthesis and selective lithium complexation. J. Chem. Soc., Perkin Trans. 2, 2297-2302.
16. Bianchi, A., Micheloni, M., and Paoletti, P. (1991) Thermodynamic aspects of the polyazacycloalkane complexes with cations and anions. Coord. Chem. Rev. 110, 17-113.
17. Springborg, J. (2003) Adamanzanes - bi- and tricyclic tetraamines and their coordination compounds. Dalton Trans. 1653-1665.
18. McCarthy, D. W., Shefer, R. E., Klinkowstein, R. E., Bass, L. A., Margenau, W. H., Cutler, C. S., Anderson, C. J., and Welch, M. J. (1997) The efficient production of high specific activity Cu-64 using a biomedical cyclotron. Nucl. Med. Biol. 24, 35-43.
19. Anderson, C. J., Dehdashti, F., Cutler, P. D., Schwarz, S. W., Laforest, R., Bass, L. A., Lewis, J. S., and McCarthy, D. W. (2001) Copper-64-TETA- octreotide as a PET imaging agent for patients with neuroendocrine tumors. J. Nucl. Med. 42, 213-221.
20. Anderson, C. J., Jones, L. A., Bass, L. A., Sherman, E. L. C., McCarthy, D. W., Cutler, P. D., Lanahan, M. V., Cristel, M. E., Lewis, J. S., and Schwarz, S. W. (1998) Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J. Nucl. Med. 39, 1944-1951.
21. Anderson, C. J., and Lewis, J. S. (2000) Radiopharmaceuticals for targeted radiotherapy of cancer. Exp. Opin. Ther. Patents 10, 1057-1069.
22. Anderson, C. J., Pajeau, T. S., Edwards, W. B., Sherman, E. L. C., Rogers, B. E., and Welch, M. J. (1995) In vitro and in vivo evaluation of copper-64-labeled octreotide conjugates7 J. Nucl. Med. 36, 2315-2325.
23. Anderson, C. J., and Welch, M. J. (1999) Radiometal-labeled agents (non-technetium) for diagnostic imaging. Chem. Rev. 99, 2219-2234.
24. Boswell, C. A., McQuade, P., Weisman, G. R., Wong, E. H., and Anderson, C. J. (2005) Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS. Nucl. Med. Biol. 32, 29-38.
25. Boswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., and Anderson, C. J. (2004) Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J. Med. Chem. 47, 1465-1474.
26. Moi, M. K., Meares, C. F., McCall, M. J., Cole, W. C., and DeNardo, S. J. (1985) Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent. Anal. Biochem. 148, 249-253.
27. Moi, M. K., DeNardo, S. J., and Meares, C. F. (1990) Stable bifunctional chelates of metals used in radiotherapy. Cancer Res. (Suppl.) 50, 789s-793s.
28. DeNardo, G. L., DeNardo, S. J., Meares, C. F., Kukis, D. L., Diril, H., McCall, M. J., Adams, G. P., Mausner, L. F., Moody, D. C., and Deshpande, S. V. (1991) Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and in patients with lymphoma. Antibody Immunoconjugates Radiopharm. 4, 777-785.
29. 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma. Clin. Cancer Res. 5, 533-541.
30. Bass, L. A., Wang, M., Welch, M. J., and Anderson, C. J. (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate Chem. 11, 527-532.
31. 3-octreotate using a cross-bridged macrocyclic chelator. Clin. Cancer Res. 10, 8674-8682.
32. Sprague, J. E., Peng, Y., Fiamengo, A. L., Woodin, K. S., Southwick, E. A., Weisman, G. R., Wong, E. H., Golen, J. A., Rheingold, A. L., and Anderson, C. J. (2007) Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J. Med. Chem. 50, 2527-2535.
33. Eisenwiener, K. P., Powell, P., and Maecke, H. R. (2000) A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling. Bioorg. Med. Chem. Lett. 10, 2133-2135.
34. 86Y-CHX- A"-octreotide: validation of a novel CHX-A" derivative suitable for peptide conjugation. J. Med. Chem. 49, 4297-4304.
35. Lewis, E. A., Allan, C. C., Boyle, R. W., and Archibald, S. J. (2004) Efficient N- and C-functionalization of cyclam macrocycles utilizing bisaminal methodology. Tetrahedron Lett. 45, 3059-3062.
36. Lewis, E. A., Boyle, R. W., and Archibald, S. J. (2004) Ultrastable complexes for in vivo use: a bifunctional chelator incorporating a cross-bridged macrocycle. Chem. Commun. 2212-2213.
37. Sun, X., Wuest, M., Weisman, G. R., Wong, E. H., Reed, D. P., Boswell, C. A., Motekaitis, R., Martell, A. E., Welch, M. J., and Anderson, C. J. (2002) Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J. Med. Chem. 45, 469-477.
38. Ma, D., Lu, F., Overstreet, T., Milenic, D. E., and Brechbiel, M. W. (2002) Novel chelating agents for potential clinicad applications of copper. Nucl. Med. Biol., 29, 91-105.
39. Jones-Wilson, T. M., Deal, K., Anderson, C. J., McCarthy, D. W., Kovacs, Z., Motekaitis, R. J., Sherry, A. D., Martell, A. E., and Welch, M. J. (1998) The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl. Med. Biol. 25, 523-530.